Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Myelodysplastic-Myeloproliferative Diseases in New Zealand
Total 0 results
Nothing found
Sponsors and Collaborators
Shanghai GeneChem Co., Ltd.
Defence Services Medical Academy (DSMA), Myanmar
Nutrabolt
Salena Killion
Pia Jaeger, MD, PhD
Huisartspraktijk Handellaan
Cogniciti
NERv Technology Inc
Zhongda Hospital, Medical School, Southeast University
The Affiliated Hospital of Xuzhou Medical University
Ministry of Public Health, Cameroon
BioNova Pharmaceuticals (Shanghai) LTD.
Impulse Dynamics, Inc.
UNITI Consortium
Smart Meter Corporation
HBSA
Université de Genève (UNIGE)
Vivid Pharma Inc.
Health Information Technology Solutions (HITS) LLC
Hungarian Dental Association
View Full List
Medical Conditions
PPA Syndrome
Alzheimer Disease Focal
PET-CT Specimen Imager
SMA - Spinal Muscular Atrophy
Pain, Breakthrough
Advanced Bladder Carcinoma
VEXAS Syndrome
Research Mentoring Skills
Infection, Bacterial
Biomarkers, Pharmacological
Failed Induction
Cerebral Arterial Disease
Vertebral Compression Fractures in Osteoporotic Patients
Radiofrequency Ablation Treatment
Eye Disease, Hereditary
Cardiovascular Primary Prevention
Endoleaks
Premature Rupture of Membranes Prolonged
Immediate Implant Placement
Old Age (Focus; Not a Recognized Condition)
View Full List
Drug Interventions
0.75% Ropivacaine
INT-747
Phase B: Triplixam / Elestar HCT
OXP005
CJ-12420 200mg + Clarithromycin 500mg
HPN328
Durvalumab + chemotherapy treatment
18F-FDG
20 mg/kg IV FL-301
Cefadroxil until drain removal
80% oxygen
Oxymorphone hydrochloride (HCl)
Microneedling with topical glycolic acid 35%.
TQB2450
5 FU continuous
Rosuvastatin
Olopatadine hydrochloride 0.2%
Acetylsalicylic acid
CNTO 6785 50 mg
Lacosamide
View Full List
CROs by country
Contract Research Organizations in Belarus
Contract Research Organizations in Bulgaria
Contract Research Organizations in China
Contract Research Organizations in Congo, DR of
Contract Research Organizations in Ecuador
Contract Research Organizations in Greece
Contract Research Organizations in Iran
Contract Research Organizations in Kenya
Contract Research Organizations in Malaysia
Contract Research Organizations in Mauritania
Contract Research Organizations in Paraguay
Contract Research Organizations in Portugal
Contract Research Organizations in Türkiye
CRO list by country
CROs in Burundi
SGS
All CROs in Burundi
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe